Literature DB >> 7107781

Micro-determination of clonazepam in plasma or serum by electron-capture gas-liquid chromatography.

N R Badcock, A C Pollard.   

Abstract

A rapid method is described for the electron-capture gas chromatographic determination of clonazepam in plasma or serum using methyl-clonazepam as an internal standard. The analysis is performed isothermally on the silicone stationary phase SP-2510DA (Supelco). With this liquid phase, gas chromatographic properties are comparable to methods involving acid hydrolysis or derivatisation. A short pre-column containing another phase is added to enhance resolution. The method involves a single extraction, requires 100 microliter of sample and has a detection limit of 3 nmol/l. Response is linear at concentrations from 5--900 nmol/l and thus clonazepam analysis both during therapy and after overdosage is possible. Plasma and serum clonazepam levels are interchangeable.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7107781     DOI: 10.1016/s0378-4347(00)80485-5

Source DB:  PubMed          Journal:  J Chromatogr


  4 in total

1.  Respiratory and sedative effects of clobazam and clonazepam in volunteers.

Authors:  J D Wildin; B J Pleuvry; G E Mawer; T Onon; L Millington
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

2.  Pharmacokinetics of a new sublingual formulation of temazepam.

Authors:  W J Russell; N R Badcock; D B Frewin; L N Sansom
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Spectrophotometric method for simultaneous estimation of escitalopram oxalate and clonazepam in tablet dosage form.

Authors:  R B Kakde; D D Satone
Journal:  Indian J Pharm Sci       Date:  2009-11       Impact factor: 0.975

4.  Plasma and cerebrospinal fluid concentration of temazepam following oral drug administration.

Authors:  N R Badcock; G A Osborne; T L Nyman; L N Sansom; W J Russell; D B Frewin
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.